Site Search
Site Search
We chatted to the VP of Ecosystem, Operations and Strategy of the PharmaLedger Association, Clarisse Dias da Mota, about the progress that’s been made since the PharmaLedger...
Niklas Blomberg, IHI’s executive director, exchanged views with Members of the European Parliament from the SANT committee about how public-private partnerships like IHI can propel...
VAC2VAC provided vital evidence to demonstrate that non-animal alternatives can reliably detect certain contaminants in medicines administered by injection.
We publish the draft topics ahead of the call launch to give applicants extra time to start preparing a proposal and building a consortium.
We publish the draft topics ahead of the call launch to give applicants extra time to start networking and preparing a proposal.
Combatting antimicrobial resistance: the legacy of the IMI COMBACTE projects
IHI took part in this year’s BIO International Convention which was held in San Diego, US on 3-6 June.
Tuberculosis (TB) is the world’s second leading killer infectious disease after COVID-19, wiping out 1.3 million people in 2022. Unfortunately, more and more patients with...